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a b s t r a c t 
In the present work, applying the whole-cell patch-clamp 
technique in voltage clamp mode, we have investigated the 
effects of different drugs, such as riluzole, Psora-4 and Tram- 
34, on the potassium currents in four human lymphoma 
cell lines. We focused on outward currents mediated by two 
potassium channels (Kv1.3 and KCa3.1), which are known 
to play a key physiological role in lymphoid cells. The cur- 
rents were evoked by voltage ramps ranging from -120 mV to 
+ 40 mV and the conductance of the two potassium channels 
was measured between + 20 mV and + 40 mV, both in the 
absence and in the presence of the specific blockers Psora- 
4 (Kv1.3; 1 μM) and Tram-34 (KCa3.1; 1 μM). The effect of 
the latter was tested after KCa3.1 channels were activated by 
riluzole 10 μM. Taken together, these data could be useful as 
an indication of the functional characteristics of the potas- 
sium channels in human lymphomas and represent a start- 
ing point for the study of potassium conductance in cellular 
models of these tumors. 
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s  pecifications Table 
Subject Cancer Research 
Specific subject area Potassium channels electrophysiology 
Type of data Raw and graph 
How data were acquired Data were acquired through a Multiclamp 700A equipment, digitized with a 
Digidata 1322A (Molecular Devices, Sunnyvale, California, USA) and the recordings 
were low-pass filtered at 3 KHz and digitally sampled at 25 KHz. 
Data format Raw 
Parameters for data collection Sample: model cells of human lymphomas 
Parameters: voltage-clamp whole-cell recordings of potassium currents evoked by 
−120 mV to + 40 mV voltage ramps. Potassium channel conductance was 
measured between + 20 mV and + 40 mV. 
Description of data collection Epstein-Barr virus-infected B lymphocytes, diffuse large B cell lymphoma cell lines 
(WSU-DLCL2, SU-DHL-4, SU-DHL-6) were cultured in RPMI 1640 and then on the 
experiment day plated on 35 mm Petri dishes for 1 hour to obtain the cell 
adhesion before performing whole-cell voltage-clamp electrophysiological 
recordings. 
Data source location Department of Experimental and Clinical Medicine, University of Florence, 
I–50,134 Florence, Italy 
Data accessibility Repository name: Zenodo 











alue of the Data 
• A functional role of ion channels in different tumor types is increasingly recognized. The role
of potassium channels has been widely studied in B lymphocyte physiology but not in lym-
phomas. Our dataset represents a start point for the study of potassium channels in cellular
models of human lymphomas. 
• The shared data can be used by researchers as a comparative model for studying the conduc-
tion properties of potassium channels in tumor cell lines and especially for non-solid tumors
(i.e. lymphocyte-derived cancer cells). 
• By providing a benchmark dataset the shared data are likely to be valuable in further de-
velopment and refinement of ion channel conductance measurements on non-adhesive cell
types. 
. Data Description 
In SU-DHL4 cell line the application of 1 μM Psora-4 produced a significant reduction of the
lope conductance from 11.6 ± 9.8 nS to 9.2 ± 8.6 nS and we measured an average net Psora-
ensitive conductance of 2.4 ± 2.5 nS ( p = 0.01, n = 10). On the other hand on SU-DHL-6 cells the
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Fig. 1. Representative time courses of Kv1.3 slope conductances measured in control conditions and in the presence 
of Psora-4 1 μM for (A) Epstein-Barr virus-infected B lymphocytes, (B) SU-DHL-4, (C) SU-DHL-6 and (D) WSU-DLCL2 
respectively. Lower row: representative traces of the corresponding experiments in control (black) and in Psora-4 (red) 
for (E) Epstein-Barr virus-infected B lymphocytes, (F) SU-DHL-4, (G) SU-DHL-6 and (H) WSU-DLCL2 respectively. 
Fig. 2. Representative time courses of KCa3.1 slope conductance measured on (A) Epstein-Barr virus-infected B lym- 
phocytes, (B) SU-DHL-4, (C) SU-DHL-6 and (D) WSU-DLCL2 cell lines. No effects were observed in any cell line upon 
KCa3.1 riluzole-mediated activation (10 μM) nor in the presence of the specific blocker TRAM-34 (1 μM). Lower row: rep- 
resentative traces of the corresponding experiments in control (blue), riluzole 10 μM (red) and in TRAM-34 (red) for (E) 
Epstein-Barr virus-infected B lymphocytes, (F) SU-DHL-4, (G) SU-DHL-6 and (H) WSU-DLCL2 respectively. (For interpre- 













application of 1 μM Psora 4 produced a non significant reduction on the slope conductance (con-
trol: 18.1 ± 6.3 nS, treated: 17.2 ± 5.4 nS, n = 7; t -test). Similar results were obtained for WSU-
DLCL2 (control: 1.3 ± 0.6 nS, treated: 0.7 ± 0.5 nS, n = 5) as well as EBV infected lymphocytes
(control: 7.0 ± 6.3 nS, treated: 6.5 ± 6.7 nS, n = 8). Fig. 1 shows the time courses under control
conditions and in the presence of Psora-4 (1 μM) representative of each cell line examined to-
gether with their relative current ramps. 
- Application of the specific blocker Tram-34 (1 μM), following KCa3.1 activation by riluzole
(10 μM), did not produced any significant effect in the studies cell lines. In SU-DHL4 cells, appli-
cation of Tram-34 (1 μM) had no effects on the slope conductance (control: 1.6 ± 2.1 nS, treated:
2.0 ± 1.8 nS, n = 5; t -test) as for SU-DHL6 cells (control: 0.5 ± 0.3 nS, treated: 0.5 ± 0.4 nS, n = 7).
Similar results were obtained also for WSU-DLCL2 (control: 2.1 ± 1.1 nS, treated: 1.0 ± 0.7 nS,
n = 5) and EBV infected lymphocytes (control: 11.1 ± 4.0 nS, treated: 10.4 ± 4.7 nS, n = 5; t -test).
Fig. 2 shows the time courses under control conditions, in the presence of the specific activator























or KCa3.1 riluzole (10 μM) and subsequently of the specific blocker Tram-34 (1 μM) representa-
ive of each cell line examined. 
- The raw data of the electrophysiological recordings are organized as follows in the Zenodo
epository: 
- Each folder is named with the name of the cell line and contains the .csv files related to the
electrophysiological recordings. Moreover, it contains an .xls file (eg. DHL-4_Kv1.3_raw.xls).
This .xls file contains the measured conductance values in the various experimental condi-
tions (ctrl, drugs etc.) relative to each single cell of that cell line. 
- Each .csv file corresponds to a cell of its relative cell line with the exception of files whose
name ends with −1 or −2 (for example 191120_C1–1, 191120_C1–2). In these cases, the
recording related to a cell has been divided in two files and −1 and −2 correspond to the
first and second part of the recording, respectively. 
- For each .csv file: column 1 is an index column representing the sample number (not useful
for analysis purposes), column 2 (Time) reports in ms each of the sample-by-sample time-
points, column 3 (Vcmd) is the potential value in mV imposed during the protocol, from
column 4 (Sw…) onwards the single sweeps of that recording are reported (column by col-
umn) and each cell of a sweep column corresponds to the current (pA) measured sample by
sample. 
- For the purposes of the analysis, the potential column (Vcmd) should be plotted on the x axis
and one (or more) sweep column(s) on the y axis. So far it will be possible to display one
(or more) ramps: from the Vcmd vs. Current plot it is then possible to perform a linear fit
in the range between + 20 and + 40 mV. The slope of this fit corresponds to the conductance
value for each ramp. 
- The time interval between one sweep and the next one is 10 s (0.16 6 6 6 67 min), therefore it is
possible to plot each single conductance value (measured as previously described) as a func-
tion of time and thus obtain the conductances time-courses as shown in the representative
figures of this manuscript. 
- Drugs administration time points for each experiment are as follows: 
Kv1.3 - DHL-4 
Cell Control (min) + Psora-4 1 μM (min) 
191,120_C1 0–5 5–15 
191,120_C2 0–3.5 3.5–13.5 
191,125_C1 no delivery no delivery 
200,110_C11 0–3.5 3.5–11 
200,110_C16 0–3 3–8 
200,113_C1 0–5 5–10 
200,113_C2 0–5.5 5.5–11 
200,113_C3 0–4 4–9 
200,120_C1 0–3.5 3.5–9.5 
200,120_C3 0–2.5 2.5–7.5 
Kv1.3 - DHL-6 
191,209_C1 0–4 4–14 
200,117_C1 0–3.5 3.5–10 
200,117_C2 0–5.5 5.5–12.5 
200,117_C3 0–5.5 5.5–11.5 
200,120_C5 0–3.5 3.5–10 
200,120_C7 0–5.5 5.5–11.5 
200,120_C8 0–5.5 5.5–10.5 













Kv1.3 - WSU-DLCL2 
191,120_C1 0–4.5 4–18 
191,120_C2 0–4.5 4.5–14.5 
191,121_C1 0–2.5 2.5–5.5 
191,121_C4 0–2.5 2.5–10.5 
191,128_C2 0–7.5 7.5–16.5 
Kv1.3 - EBV 
200,108_C4 0–2 2–10 
200,108_C5 0–3.5 3.5–13.5 
200,109_C4 0–1 1–4 
200,109_C7 0–1 1–4 
200,109_C9 0–6 6–11 
N200109_C2 0–5 5–10 
N200109_C3 0–4.5 4.5–10.5 
N200109_C4 0–3.5 3.5–8.5 
KCa3.1 - DHL-4 
Cell Control (min) + Riluzole 10 μM (min) + TRAM-34 1 μM (min) 
191,128_C5 0–5 5–10 10-end 
191,209_C3 0–4 4–9 9-end 
191,211_C6 0–12 12–17 17-end 
191,212_C3 0–2.5 2.5–10.5 10.5-end 
191,212_C4 0–6 6–12.5 12.5-end 
KCa3.1 - DHL-6 
191,212_C1 0–3 3–6 6-end 
191,212_C2 0–9 9–14 14-end 
191,212_C5 0–5 5–12 12-end 
191,216_C2 0–4 4–7 7-end 
191,216_C4 0–3 3–6.5 6.5-end 
KCa3.1 - WSU-DLCL2 
191,120_C1 0–4.5 4.5–10 10-end 
191,120_C6 0–10 10–20 20-end 
191,120_C8 0-end no delivery no delivery 
191,121_C10 0–3 3–5 5-end 
191,121_C8 0-end no delivery no delivery 
200,117_C11 0–3 3–7 7-end 
2. Experimental Design, Materials and Methods 
Human lymphoma cell lines. Epstein-Barr virus-infected B lymphocytes were previously gen-
erated in our laboratory [1] . Epstein-Barr virus-infected B lymphocytes, the DLBCL (GC subtype)
cell lines SU-DHL4 and SU-DHL6 were cultured in RPMI 1640 medium supplemented with 2 mM
l -glutamine, 10% bovine calf serum (HyClone), 10 0 U/mL penicillin, and 10 0 μg/mL streptomycin.
The DLBCL, SU-DHL4 and SU-DHL6 cell lines are derived from germinal center B-cell type diffuse
large B-cell lymphoma, which is the most common type of B-cell lymphoma. These cell repre-
sent in vitro models to functionally study the ion channels expression pattern recently reported
in clinical specimens [2] . 
Electrophysiological recordings. Cells were plated on the experimental day directly on plastic.
Electrophysiological recordings has been performed at room temperature ( ∼25 °C) in the whole-
cell configuration of the patch-clamp technique, after 1 hour in an incubator at 37 °C [3–5] . The
patch pipettes were pulled from borosilicate glass capillary tubes, their resistance was 4–5 M 
and their capacitances were manually compensated up to 90–95% after the reaching of a stable
gigaseal. Experimental protocols and data acquisition has been performed with the Multiclamp













































00A amplifier and pCLAMP 9.2 software (Molecular Devices, Sunnyvale, California, USA) has
een used for data analysis. All the outward potassium currents were measured with a 25KHz
ampling rate and a 3 KHz low-pass filter. Cells’ identification and patch has been performed
t 40x magnification with a Nikon Eclipse TE300 microscope (Nikon Instruments Inc.), equipped
ith a Photometrics CoolSNAP CF camera (Teledyne Photometrics, Tucson AZ). Cells membrane
otentials were held at −80 mV and outward potassium currents were elicited by 200 ms voltage
amps ( −120 to + 40 mV) with an intersweep interval of 10 s [6] . The internal pipette solution
or Kv1.3 conductances measurement contained (in mM): 130 K + aspartate, 10 NaCl, 4 CaCl2,
 MgCl2, 10 Hepes–NaOH, 10 EGTA, pH 7.3. The external solution, instead, contained (in mM):
30 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 5 Glucose (EK = −80 mV), pH of 7.4. For KCa3.1
urrents a different internal pipette solution was used (in mM): 145 K + aspartate, 8.55 CaCl2, 2
gCl2, 10 HEPES, 10 EGTA, pH 7.2. In this case, the external solution was a Na + aspartate Ringer,
ontaining (in mM): 160 Na + aspartate, 4.5 KCl, 2 CaCl2, 1 MgCl2, 5 Hepes–NaOH, pH 7.4. The
Slope values have been measured offline between + 20 and + 40 mV potentials range with the
lampfit software. The difference between the elicited currents recorded in control condition
nd the ones recorded in the presence of Psora-4 (1 μM) represented the Psora-4-sensitive cur-
ent (Kv1.3 current). The effects of the KCa3.1 specific inhibitor TRAM-34 at 1 μM, instead, has
een assessed on the maximal KCa3.1 activation, induced by Riluzole (10 μM). The 1 μM concen-
ration for both Psora-4 and TRAM-34 was chosen because of its capability of evoking a maximal
ffect and drugs has been applied for at leat 5 min. Resting membrane potential (VREST) values
ere measured in I-0 mode. 
Statistics. Parametric tests were used for statistical analysis, i.e., paired and unpaired t -test.
ata are reported as mean ± SD and median ± interquartile range (IQR). The normality of data
istribution was checked with Kolmogorov–Smirnov test. Statistical analysis was performed us-
ng Prism 6 software (GraphPad Software, San Diego, CA, USA). All statistical tests were two
ailed with a significance level of 0.05. 
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